Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case-control studies using two primary care databases in Europe

被引:11
作者
Brauer, Ruth [1 ,2 ]
Douglas, Ian [1 ]
Garcia Rodriguez, Luis Alberto [3 ]
Downey, Gerald [2 ]
Huerta, Consuelo [4 ]
de Abajo, Francisco [5 ]
Bate, Andrew [6 ]
Tepie, Maurille Feudjo [2 ]
de Groot, Mark C. H. [7 ]
Schlienger, Raymond [8 ]
Reynolds, Robert [9 ]
Smeeth, Liam [1 ]
Klungel, Olaf [7 ]
Ruigomez, Ana [3 ]
机构
[1] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England
[2] Amgen Ltd, London, England
[3] Fdn Ctr Espanol Invest Farmacoepidemiol CEIFE, Madrid, Spain
[4] AEMPS, Med Human Use Dept, Div Pharmacoepidemiol & Pharmacovigilance, Madrid, Spain
[5] Univ Alcala de Henares, Dept Biomed Sci, Univ Hosp Principe Asturias, Clin Pharmacol Unit, E-28871 Alcala De Henares, Spain
[6] Pfizer Ltd, Epidemiol, Tadworth, England
[7] Univ Utrecht, Fac Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands
[8] Novartis Pharma AG, Basel, Switzerland
[9] Pfizer Res & Dev, Epidemiol, New York, NY USA
关键词
primary care databases; incidence rate; case-control study; acute liver injury; antibiotics; BIFAP; CPRD; pharmacoepidemiology; CLINICAL-FEATURES; SAFETY; HEPATOTOXICITY;
D O I
10.1002/pds.3861
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
PurposeTo assess the impact of varying study designs, exposure and outcome definitions on the risk of acute liver injury (ALI) associated with antibiotic use. MethodsThe source population comprised of patients registered in two primary care databases, in the UK and in Spain. We identified a cohort consisting of new users of antibiotics during the study period (2004-2009) and non-users during the study period or in the previous year. Cases with ALI were identified within this cohort and classified as definite or probable, based on recorded medical information. The relative risk (RR) of ALI associated with antibiotic use was computed using Poisson regression. For the nested case-control analyses, up to five controls were matched to each case by age, sex, date and practice (in CPRD) and odds ratios (OR) were computed with conditional logistic regression. ResultsThe age, sex and year adjusted RRs of definite ALI in the current antibiotic use periods was 10.04 (95% CI: 6.97-14.47) in CPRD and 5.76 (95% CI: 3.46-9.59) in BIFAP. In the case-control analyses adjusting for life-style, comorbidities and use of medications, the OR of ALI for current users of antibiotics was and 5.7 (95% CI: 3.46-9.36) in CPRD and 2.6 (95% CI: 1.26-5.37) in BIFAP. ConclusionGuided by a common protocol, both cohort and case-control study designs found an increased risk of ALI associated with the use of antibiotics in both databases, independent of the exposure and case definitions used. However, the magnitude of the risk was higher in CPRD compared to BIFAP. Copyright (c) 2016 John Wiley & Sons, Ltd.
引用
收藏
页码:29 / 38
页数:10
相关论文
共 27 条
[1]  
Abbing-Karahagopian VKX, 2011, PHARMACOEPIDEM DR S, V20, pS1
[2]   Outcome of acute idiosyncratic drug-induced liver injury:: Long-term follow-up in a hepatotoxicity registry [J].
Andrade, Raul J. ;
Lucena, M. Isabel ;
Kaplowitz, Neil ;
Garcia-Munoz, Beatriz ;
Borraz, Yolanda ;
Pachkoria, Ketevan ;
Garcia-Cortes, Miren ;
Fernandez, M. Carmen ;
Pelaez, Gloria ;
Rodrigo, Luis ;
Duran, Jose A. ;
Costa, Joan ;
Planas, Ramon ;
Barriocanal, Anabel ;
Guarner, Carlos ;
Romero-Gomez, Manuel ;
Munoz-Yague, Teresa ;
Salmeron, Javier ;
Hidalgo, Ramon .
HEPATOLOGY, 2006, 44 (06) :1581-1588
[3]   Hepatic safety of antibiotics used in primary care [J].
Andrade, Raul J. ;
Tulkens, Paul M. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (07) :1431-1446
[4]  
[Anonymous], COMP DAT MED REC PRI
[5]   DRUG SAFETY DISCONTINUATIONS IN THE UNITED-KINGDOM, THE UNITED-STATES, AND SPAIN FROM 1974 THROUGH 1993 - A REGULATORY PERSPECTIVE [J].
BAKKE, OM ;
MANOCCHIA, M ;
DEABAJO, F ;
KAITIN, KI ;
LASAGNA, L .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (01) :108-117
[6]   Review article: drug-induced liver injury in clinical practice [J].
Bjornsson, E. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (01) :3-13
[7]   Prevalence of antibiotic use: a comparison across various European health care data sources [J].
Brauer, Ruth ;
Ruigomez, Ana ;
Downey, Gerry ;
Bate, Andrew ;
Garcia Rodriguez, Luis Alberto ;
Huerta, Consuelo ;
Gil, Miguel ;
de Abajo, Francisco ;
Requena, Gema ;
Alvarez, Yolanda ;
Slattery, Jim ;
de Groot, Mark ;
Souverein, Patrick ;
Hesse, Ulrik ;
Rottenkolber, Marietta ;
Schmiedl, Sven ;
de Vries, Frank ;
Tepie, Maurille Feudjo ;
Schlienger, Raymond ;
Smeeth, Liam ;
Douglas, Ian ;
Reynolds, Robert ;
Klungel, Olaf .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 :11-20
[8]   Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-induced Liver Injury in the United States [J].
Chalasani, Naga ;
Fontana, Robert J. ;
Bonkovsky, Herbert L. ;
Watkins, Paul B. ;
Davern, Timothy ;
Serrano, Jose ;
Yang, Hongqiu ;
Rochon, James .
GASTROENTEROLOGY, 2008, 135 (06) :1924-1934
[9]   Acute and clinically relevant drug-induced liver injury:: a population based case-control study [J].
de Abajo, FJ ;
Montero, D ;
Madurga, M ;
Rodríguez, LAG .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (01) :71-80
[10]   CHOLESTATIC HEPATITIS ASSOCIATED WITH FLUCLOXACILLIN [J].
DERBY, LE ;
JICK, H ;
HENRY, DA ;
DEAN, AD .
MEDICAL JOURNAL OF AUSTRALIA, 1993, 158 (09) :596-600